← All companies

SNDX

Syndax Pharmaceuticals, Inc.

SNDX Nasdaq Pharmaceutical Preparations EDGAR ↗

$19.08

-0.16 -0.83%

Key statistics

from XBRL data in SEC filings

Market cap

$1.70B

Revenue (TTM)

$252M

Net income (TTM)

-$221M

EPS (TTM)

$-2.51

P/E ratio

—

Dividend yield

—

Free cash flow

-$323M

Cash

$336M

Total assets

$704M

Gross margin

—

52-week range

$11.91 – $25.59

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 4, 2026 8-K Results of operations (earnings release) Aug 4, 2026 8-K Other events Jul 14, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 10, 2026 8-K Director or officer change; Shareholder vote results Jun 10, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 4, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Amended charter or bylaws Dec 19, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Other events Oct 24, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Director or officer change Jun 26, 2025 8-K Director or officer change; Regulation FD disclosure May 16, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release); Other events May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release); Other events Mar 3, 2025 8-K Director or officer change Dec 20, 2024 8-K Other events Nov 18, 2024 8-K Other events Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Entered a material agreement Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure May 15, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change; Regulation FD disclosure Mar 18, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Other events Dec 20, 2023 8-K Entered a material agreement Dec 15, 2023 8-K Other events Dec 12, 2023